Shuttle Pharmaceuticals Holdings, Inc. SHPH
4.01
0.01
0.25%
as of 25 Sep
- Market cap
- $15.6M
- P/E
- 34.7×
Follow SHPH
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '18 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.25 | 1.03 | 0.16 | 0.23 | 8.79 | 5.37 | 1.44 | 0.06 |
Net Debt/EBITDA |
(1.42) | (0.08) | (1.54) | 0.26 | 4.29 | 1.42 | 0.29 | 0.03 |
Debt/Assets |
259.19% | 64.38% | 149.96% | 9.58% | 0.00% | 2.27% | 0.00% | 0.00% |
Debt/Equity |
(1.11) | 14.55 | (0.48) | (0.04) | 0.00 | 0.03 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.95 | 0.91 | 0.03 | 0.24 | 0.40 | 0.85 | 0.80 | 0.81 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | (8.68) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 487.62% | 109.31% | 75.65% | (223.05%) | (112.37%) | (383.83%) | (791.04%) | |
| 0.00% | (168.62%) | (155.98%) | (209.97%) | (145.02%) | (90.28%) | (216.24%) | (180.58%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (387.84%) |
Return on Tangible Assets |
75.13% | (2,981.43%) | 57.98% | 74.31% | (88.60%) | (144.08%) | (1,312.96%) | 157.41% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.01) | (0.04) | 0.00 | (63.89) | (493.78) | (746.68) | (637.15) | (76.55) |
Cash per Share |
0.00 | 0.03 | 0.01 | 107.38 | 1,558.74 | 728.48 | 166.97 | 2.04 |
Shareholders Equity per Share |
(0.02) | 0.00 | (0.12) | (346.40) | 1,421.83 | 540.77 | 61.67 | 13.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.02) | 0.00 | (0.12) | (346.40) | 1,421.83 | 540.77 | 61.67 | 13.76 |
Free Cash Flow |
(0.20) | (0.57) | (0.03) | (0.30) | (2.67) | (5.60) | (7.33) | (12.54) |
Working Capital |
(0.30) | 0.02 | (1.76) | (1.71) | 7.60 | 4.55 | 0.68 | (7.46) |
Capital Expenditures |
— | — | (0.01) | — | — | (0.02) | — | (3.06) |
Net Current Asset Value |
(0.30) | 0.02 | (1.89) | (1.77) | 7.60 | 3.70 | 0.41 | (7.72) |
| Other line items | ||||||||
Quick Ratio |
0.25 | 0.60 | 0.16 | 0.23 | 8.63 | 5.24 | 1.25 | 0.04 |
Depreciation/Fixed assets |
0.99 | 22.50 | 0.28 | 3.45 | 30.43 | 85.88 | 55.92 | 20.35 |
Cash ROIC |
(274.13%) | (72.77%) | 29.47% | 30.06% | (16.64%) | (58.07%) | (279.41%) | (366.98%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
1,543.93 | 622.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.01) | (0.04) | 0.00 | (63.89) | (493.78) | (744.15) | (637.15) | (57.89) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (2.53) | 0.00 | (18.66) |
Average Receivables |
— | 0.03 | 0.11 | — | — | — | — | — |
Average Payables |
— | 0.05 | — | 0.43 | 0.48 | 0.21 | 0.44 | 1.03 |
Average Assets |
— | 0.37 | 0.58 | 0.60 | 4.65 | 7.30 | 4.23 | 6.49 |
Average Common Equity |
— | (0.13) | (0.83) | (1.66) | 3.02 | 5.87 | 2.38 | 1.48 |
Capex to Sales |
— | — | — | — | — | 0.00 | — | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates